A First-in-Human Study of CEE321 in Adult Subjects

Clinical trial NCT04612062 · COMPLETED

Trial details

NCT number: NCT04612062
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2020-02-27
Primary completion: 2021-05-16
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.